SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Stock (1mL)

NATtrol™ SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Stock is formulated with purified, intact viral particles. that have been chemically modified to render them non-infectious and refrigerator stable. Each vial contains 1.0 mL of NATtrol™ SARS-CoV-2 Variant B.1.351 stock in a proprietary matrix at the target concentration

NATtrol™ SARS-CoV-2 Variant B.1.351 stock is designed to evaluate the performance of nucleic acid tests for determination of the presence of SARS-CoV-2 Variant B.1.351 RNA. NATtrol™ SARS-CoV-2 Variant B.1.351 stock enables laboratories to monitor test variation, lot-to-lot test kit performance, operator variation, and can provide assistance in identifying random or systemic error.

FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES• Quality control materials should be used in accordance with local, state, federal, and accreditation requirements. • This product is not intended to replace the manufacturer’s controls provided with the assay.